Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands
Aims: The prevalence of atrial fibrillation (AF) has increased over the past years due to aging of the population, and healthcare costs associated with AF reflect a significant financial burden. The aim of this study was to explore predictors for the real-world AF-related in-hospital costs in patients that recently initiated anticoagulation with acenocoumarol or dabigatran.Methods: Predictors for claimed total hospital care costs and cardiology costs in AF patients were explored by using hospital financial claims data from propensity score matched patient groups in a large Dutch community hosp... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2017 |
Reihe/Periodikum: | Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766 |
Schlagwörter: | Anticoagulation / dabigatran / acenocoumarol / atrial fibrillation / hospital costs / cardiology costs / RISK STRATIFICATION SCHEMES / HEALTH-CARE UTILIZATION / ISCHEMIC-STROKE / ORAL ANTICOAGULANTS / WARFARIN / APIXABAN / SAFETY / COHORT |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29191702 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/929f340d-c0fe-4a2c-8989-644b402aa573 |